NASDAQ: MREO
Mereo Biopharma Group PLC Stock Ownership - Who owns Mereo Biopharma Group?

Insider buying vs selling

Have Mereo Biopharma Group PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MREO insiders and whales buy or sell their stock.

MREO Shareholders

What type of owners hold Mereo Biopharma Group PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rubric Capital Management LP4.02%31,950,000$61.34MInsider
Janus Henderson Group PLC2.22%17,688,592$33.96MInstitution
Rubric Capital Management LP1.92%15,307,347$29.39MInstitution
Frazier Life Sciences Management LP1.19%9,440,112$18.13MInstitution
Mangrove Partners IM LLC1.09%8,636,485$16.58MInstitution
Deerfield Management Company LP0.84%6,710,429$12.88MInstitution
Alkeon Capital Management LLC0.59%4,698,100$9.02MInstitution
Rock Springs Capital Management LP0.56%4,465,292$8.57MInstitution
683 Capital Management LLC0.55%4,350,000$8.35MInstitution
Clearline Capital LP0.45%3,618,163$6.95MInstitution

1 of 3

MREO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MREO12.39%4.19%
GNLX19.59%7.60%Net Selling
ALDX57.21%27.89%Net SellingNet Selling
CTNM49.41%9.63%Net Selling
CADL41.97%31.11%Net Buying

Mereo Biopharma Group Stock Ownership FAQ

Who owns Mereo Biopharma Group?

Mereo Biopharma Group (NASDAQ: MREO) is owned by 12.39% institutional shareholders, 4.19% Mereo Biopharma Group insiders, and 83.42% retail investors. Rubric Capital Management LP is the largest individual Mereo Biopharma Group shareholder, owning 31.95M shares representing 4.02% of the company. Rubric Capital Management LP's Mereo Biopharma Group shares are currently valued at $60.39M.

If you're new to stock investing, here's how to buy Mereo Biopharma Group stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.